Logo image of ZBAO

ZHIBAO TECHNOLOGY INC (ZBAO) Stock Fundamental Analysis

USA - NASDAQ:ZBAO - KYG989MC1063 - Common Stock

1.03 USD
+0.01 (+0.49%)
Last: 9/26/2025, 8:00:02 PM
1.04 USD
+0.01 (+0.97%)
After Hours: 9/26/2025, 8:00:02 PM
Fundamental Rating

4

Taking everything into account, ZBAO scores 4 out of 10 in our fundamental rating. ZBAO was compared to 146 industry peers in the Insurance industry. While ZBAO seems to be doing ok healthwise, there are quite some concerns on its profitability. ZBAO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ZBAO was profitable.
ZBAO Yearly Net Income VS EBIT VS OCF VS FCFZBAO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 10M -10M -20M -30M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.73%, ZBAO is in the better half of the industry, outperforming 75.34% of the companies in the same industry.
The Return On Equity of ZBAO (15.95%) is better than 74.66% of its industry peers.
The Return On Invested Capital of ZBAO (7.56%) is better than 90.41% of its industry peers.
Industry RankSector Rank
ROA 3.73%
ROE 15.95%
ROIC 7.56%
ROA(3y)-4.15%
ROA(5y)N/A
ROE(3y)-13.33%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZBAO Yearly ROA, ROE, ROICZBAO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

ZBAO has a Profit Margin of 3.56%. This is in the lower half of the industry: ZBAO underperforms 67.81% of its industry peers.
ZBAO has a worse Operating Margin (4.22%) than 77.40% of its industry peers.
With an excellent Gross Margin value of 35.55%, ZBAO belongs to the best of the industry, outperforming 91.10% of the companies in the same industry.
In the last couple of years the Gross Margin of ZBAO has declined.
Industry RankSector Rank
OM 4.22%
PM (TTM) 3.56%
GM 35.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.48%
GM growth 5YN/A
ZBAO Yearly Profit, Operating, Gross MarginsZBAO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ZBAO is destroying value.
The number of shares outstanding for ZBAO has been increased compared to 1 year ago.
The debt/assets ratio for ZBAO has been reduced compared to a year ago.
ZBAO Yearly Shares OutstandingZBAO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
ZBAO Yearly Total Debt VS Total AssetsZBAO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of 1.42, we must say that ZBAO is in the distress zone and has some risk of bankruptcy.
ZBAO has a better Altman-Z score (1.42) than 82.19% of its industry peers.
A Debt/Equity ratio of 0.67 indicates that ZBAO is somewhat dependend on debt financing.
ZBAO has a Debt to Equity ratio of 0.67. This is amonst the worse of the industry: ZBAO underperforms 82.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Altman-Z 1.42
ROIC/WACC0.87
WACC8.68%
ZBAO Yearly LT Debt VS Equity VS FCFZBAO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

ZBAO has a Current Ratio of 1.27. This is a normal value and indicates that ZBAO is financially healthy and should not expect problems in meeting its short term obligations.
ZBAO has a Current ratio of 1.27. This is amongst the best in the industry. ZBAO outperforms 82.19% of its industry peers.
ZBAO has a Quick Ratio of 1.27. This is a normal value and indicates that ZBAO is financially healthy and should not expect problems in meeting its short term obligations.
ZBAO has a better Quick ratio (1.27) than 82.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
ZBAO Yearly Current Assets VS Current LiabilitesZBAO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 119.81% over the past year.
ZBAO shows a strong growth in Revenue. In the last year, the Revenue has grown by 45.81%.
Measured over the past years, ZBAO shows a very strong growth in Revenue. The Revenue has been growing by 59.09% on average per year.
EPS 1Y (TTM)119.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.21%
Revenue 1Y (TTM)45.81%
Revenue growth 3Y59.09%
Revenue growth 5YN/A
Sales Q2Q%73.73%

3.2 Future

Based on estimates for the next years, ZBAO will show a very strong growth in Earnings Per Share. The EPS will grow by 69.56% on average per year.
The Revenue is expected to decrease by -46.22% on average over the next years. This is quite bad
EPS Next Y57.5%
EPS Next 2Y69.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-79.42%
Revenue Next 2Y-46.22%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ZBAO Yearly Revenue VS EstimatesZBAO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ZBAO Yearly EPS VS EstimatesZBAO Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.2 0.4 0.6 0.8

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.60, which indicates a rather expensive current valuation of ZBAO.
Based on the Price/Earnings ratio, ZBAO is valued a bit more expensive than 70.55% of the companies in the same industry.
ZBAO is valuated rather cheaply when we compare the Price/Earnings ratio to 27.32, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 6.26 indicates a rather cheap valuation of ZBAO.
Based on the Price/Forward Earnings ratio, ZBAO is valued a bit cheaper than 76.71% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.89. ZBAO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 20.6
Fwd PE 6.26
ZBAO Price Earnings VS Forward Price EarningsZBAO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ZBAO.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.99
ZBAO Per share dataZBAO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1

4.3 Compensation for Growth

ZBAO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ZBAO's earnings are expected to grow with 69.56% in the coming years.
PEG (NY)0.36
PEG (5Y)N/A
EPS Next 2Y69.56%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ZBAO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZHIBAO TECHNOLOGY INC

NASDAQ:ZBAO (9/26/2025, 8:00:02 PM)

After market: 1.04 +0.01 (+0.97%)

1.03

+0.01 (+0.49%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.55%
Inst Owner ChangeN/A
Ins Owners1.32%
Ins Owner ChangeN/A
Market Cap33.01M
AnalystsN/A
Price TargetN/A
Short Float %0.24%
Short Ratio0.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-85.17%
Revenue NY rev (3m)-85.17%
Valuation
Industry RankSector Rank
PE 20.6
Fwd PE 6.26
P/S 0.71
P/FCF N/A
P/OCF N/A
P/B 3.2
P/tB 3.28
EV/EBITDA 11.99
EPS(TTM)0.05
EY4.85%
EPS(NY)0.16
Fwd EY15.99%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.45
BVpS0.32
TBVpS0.31
PEG (NY)0.36
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.73%
ROE 15.95%
ROCE 17.23%
ROIC 7.56%
ROICexc 9.64%
ROICexgc 9.83%
OM 4.22%
PM (TTM) 3.56%
GM 35.55%
FCFM N/A
ROA(3y)-4.15%
ROA(5y)N/A
ROE(3y)-13.33%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.48%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Debt/EBITDA 2.87
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z 1.42
F-ScoreN/A
WACC8.68%
ROIC/WACC0.87
Cap/Depr(3y)25.8%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.59%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)119.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.21%
EPS Next Y57.5%
EPS Next 2Y69.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)45.81%
Revenue growth 3Y59.09%
Revenue growth 5YN/A
Sales Q2Q%73.73%
Revenue Next Year-79.42%
Revenue Next 2Y-46.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y126.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year695.73%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-50.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-238.94%
OCF growth 3YN/A
OCF growth 5YN/A